Form 4: Standex International Director Thomas E. Chorman Acquires Shares Through Restricted Stock Grant
SEC Form 4 Filing
Director Thomas E. Chorman acquired 732 shares of Standex International Corp. through a restricted stock grant.
Summary
- On October 24, 2024, Thomas E. Chorman, a director of Standex International Corporation, acquired 732 shares of common stock.
- The acquisition was a grant of restricted stock under the company's 2018 Omnibus Incentive Plan.
- The restricted stock vests three years after the grant date.
- Following the transaction, Chorman beneficially owns 13,590 shares of Standex International Corporation.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally viewed favorably, but the impact is limited as it's a relatively small number of shares granted as part of a compensation plan.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.
Future Outlook
The restricted stock vests three years from the grant date, suggesting a long-term commitment by the director.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. Restricted stock grants are a common form of executive compensation.
Stakeholder Impact
- The transaction could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 10/24/2024 | Date of transaction: Thomas E. Chorman acquired 732 shares of Standex International Corp. |
| 10/25/2024 | Date of signature on the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.